169 related articles for article (PubMed ID: 29516925)
1. Expression of p53, epidermal growth factor receptor, c-erbB2 in oral leukoplakias and oral squamous cell carcinomas.
Singla S; Singla G; Zaheer S; Rawat DS; Mandal AK
J Cancer Res Ther; 2018; 14(2):388-393. PubMed ID: 29516925
[TBL] [Abstract][Full Text] [Related]
2. [Relationship of oral leukoplakia and cancer by immunohistochemical expression of EGF-receptor].
Yamada T
Kokubyo Gakkai Zasshi; 1990 Mar; 57(1):187-200. PubMed ID: 2370442
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
[TBL] [Abstract][Full Text] [Related]
4. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications.
Agarwal S; Mathur M; Srivastava A; Ralhan R
Oral Oncol; 1999 Mar; 35(2):209-16. PubMed ID: 10435158
[TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma and p53 protein expression in pre-malignant oral lesions and oral squamous cell carcinoma.
de Oliveira MG; Ramalho LM; Gaião L; Pozza DH; de Mello RA
Mol Med Rep; 2012 Jul; 6(1):163-6. PubMed ID: 22576742
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of p53 and Ki 67 and lack of c-erbB2 expression in oral leukoplakias in India.
Kumar P; Kane S; Rathod GP
Braz Oral Res; 2012; 26(3):228-34. PubMed ID: 22641442
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclin dependent kinase inhibitor p21waf1/cip1 in premalignant and malignant oral lesions: relationship with p53 status.
Agarwal S; Mathur M; Shukla NK; Ralhan R
Oral Oncol; 1998 Sep; 34(5):353-60. PubMed ID: 9861340
[TBL] [Abstract][Full Text] [Related]
8. Expression of biomarkers (p53, transforming growth factor alpha, epidermal growth factor receptor, c-erbB-2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas.
Ibrahim SO; Lillehaug JR; Johannessen AC; Liavaag PG; Nilsen R; Vasstrand EN
Oral Oncol; 1999 May; 35(3):302-13. PubMed ID: 10621852
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of COX-2, EGFR, and p53 as biomarkers of non-dysplastic oral leukoplakias.
Prado SM; Cedrún JL; Rey RL; Villaamil VM; García AA; Ayerbes MV; Aparicio LA
Exp Mol Pathol; 2010 Oct; 89(2):197-203. PubMed ID: 20599939
[TBL] [Abstract][Full Text] [Related]
10. Quantitative cell-cycle protein expression in oral cancer assessed by computer-assisted system.
Soares CP; Zuanon JA; Teresa DB; Fregonezi PA; Neto CB; Oliveira MR; Donadi EA; Martinelli-Kläy CP; Soares EG
Histol Histopathol; 2006 Jul; 21(7):721-8. PubMed ID: 16598671
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of epidermal growth factor (EGF) and EGF receptor in human oral mucosa and its malignancy.
Shirasuna K; Hayashido Y; Sugiyama M; Yoshioka H; Matsuya T
Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):349-53. PubMed ID: 2024456
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer.
Taoudi Benchekroun M; Saintigny P; Thomas SM; El-Naggar AK; Papadimitrakopoulou V; Ren H; Lang W; Fan YH; Huang J; Feng L; Lee JJ; Kim ES; Hong WK; Johnson FM; Grandis JR; Mao L
Cancer Prev Res (Phila); 2010 Jul; 3(7):800-9. PubMed ID: 20570883
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-alpha overexpression in proliferative verrucous leukoplakia and oral squamous cell carcinoma: an immunohistochemical study.
Kannan R; Bijur GN; Mallery SR; Beck FM; Sabourin CL; Jewell SD; Schuller DE; Stoner GD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jul; 82(1):69-74. PubMed ID: 8843456
[TBL] [Abstract][Full Text] [Related]
18. Recurrent copy number alterations involving EGFR, CDKN2A, and CCND1 in oral premalignant lesions.
Jäwert F; Fehr A; Öhman J; Stenman G; Kjeller G
J Oral Pathol Med; 2022 Jul; 51(6):546-552. PubMed ID: 35488777
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
Shintani S; Yoshihama Y; Emilio AR; Matsumura T
Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
[TBL] [Abstract][Full Text] [Related]
20. [Expressions of PDCD5 and p53 in oral leukoplakia and oral squamous cell carcinoma].
Zhao XY; Liu HW; Wei MJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):429-32. PubMed ID: 16086069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
